# Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure

> **NCT00869115** · PHASE1 · WITHDRAWN · sponsor: **Debiopharm International SA**

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Istaroxime
- **DRUG:** Istaroxime
- **DRUG:** Istaroxime
- **DRUG:** Istaroxime

## Key facts

- **NCT ID:** NCT00869115
- **Lead sponsor:** Debiopharm International SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was not started due to a re-evaluation of the istaroxime development program
- **Last updated:** 2014-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00869115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00869115, "Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00869115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*